Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Acq. announced

Ikena Oncology, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
01/05/2023 4 Santillana Sergio L. (Chief Medical Officer) has filed a Form 4 on Ikena Oncology, Inc.
Txns: Granted 105,000 options to buy @ $2.62, valued at $275.1k
01/05/2023 4 Ecsedy Jeffrey (Chief Development Officer) has filed a Form 4 on Ikena Oncology, Inc.
Txns: Granted 105,000 options to buy @ $2.62, valued at $275.1k
01/05/2023 4 Zhang Xiaoyan Michelle (Chief Scientific Officer) has filed a Form 4 on Ikena Oncology, Inc.
Txns: Granted 105,000 options to buy @ $2.62, valued at $275.1k
01/05/2023 4 Manfredi Mark (President & CEO) has filed a Form 4 on Ikena Oncology, Inc.
Txns: Granted 220,000 options to buy @ $2.62, valued at $576.4k
01/05/2023 4 Marango Jotin (CFO & Head of Corp. Dev.) has filed a Form 4 on Ikena Oncology, Inc.
Txns: Granted 105,000 options to buy @ $2.62, valued at $275.1k
12/19/2022 4 Hughes Owen (Director) has filed a Form 4 on Ikena Oncology, Inc.
Txns: Granted 35,040 options to buy @ $2.62, valued at $91.8k
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/25/2022 4 Marango Jotin (CFO & Head of Corp. Dev.) has filed a Form 4 on Ikena Oncology, Inc.
Txns: Granted 397,199 options to buy @ $5.88, valued at $2.3M
02/04/2022 4 Zhang Xiaoyan Michelle (Chief Scientific Officer) has filed a Form 4 on Ikena Oncology, Inc.
Txns: Granted 40,000 options to buy @ $11.45, valued at $458k
02/04/2022 4 Santillana Sergio L. (Chief Medical Officer) has filed a Form 4 on Ikena Oncology, Inc.
Txns: Granted 70,400 options to buy @ $11.45, valued at $806.1k
02/04/2022 4 Manfredi Mark (President & CEO) has filed a Form 4 on Ikena Oncology, Inc.
Txns: Granted 238,900 options to buy @ $9.76, valued at $2.3M
02/04/2022 4 Ecsedy Jeffrey (Chief Development Officer) has filed a Form 4 on Ikena Oncology, Inc.
Txns: Granted 59,360 options to buy @ $11.45, valued at $679.7k
02/04/2022 4 Tessier Maude (Chief Business Officer) has filed a Form 4 on Ikena Oncology, Inc.
Txns: Granted 40,000 options to buy @ $11.45, valued at $458k
01/25/2022 4 Wooster Richard (Director) has filed a Form 4 on Ikena Oncology, Inc.
Txns: Granted 29,200 options to buy @ $11.06, valued at $323k
01/20/2022 4 Tessier Maude (Chief Business Officer) has filed a Form 4 on Ikena Oncology, Inc.
Txns: Exercised 38,915 options to buy @ $2.94, valued at $114.4k
Exercised 24,606 options to buy @ $4.15, valued at $102.1k
Exercised 8,265 options to buy @ $4.51, valued at $37.3k
01/12/2022 4 Zhang Xiaoyan Michelle (Chief Scientific Officer) has filed a Form 4 on Ikena Oncology, Inc.
Txns: Sold 36 shares @ $12, valued at $432
Sold 964 shares @ $12, valued at $11.6k
Exercised 36 options to buy @ $2.1462, valued at $77.3
Exercised 964 options to buy @ $2.1462, valued at $2.1k
12/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/23/2021 4 Zhang Xiaoyan Michelle (Chief Scientific Officer) has filed a Form 4 on Ikena Oncology, Inc.
Txns: Granted 176,699 options to buy @ $13.75, valued at $2.4M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy